News|Articles|June 1, 2014
Half of All Drugs Today are Developed Through Collaborations
Tufts CSDD
Advertisement
Facing high innovation risk, costs, and inefficiencies, sponsor companies have increasingly engaged in establishing risk-sharing partnerships, including joint ventures, mergers and acquisitions, in-licensing, and co-development arrangements.
To understand collaboration practices and preferences, the Tufts Center for the Study of Drug Development (Tufts CSDD) examined the development and approval histories of 289 drugs approved by the FDA between 2000 through 2011. Of these drugs, half involved a collaborative development arrangement, with licensing deals being the most common risk-sharing approach.
A quarter of these collaborations were part of a merger, acquisition, or co-development arrangement. Tufts CSDD also found that the prevalence for risk-sharing collaborations varied by therapeutic area, with approved central nervous system drugs having the highest prevalence.
The growth of collaborative risk-sharing innovation models will likely accelerate in a drug-development operating environment characterized by scientifically and logistically complex and demanding protocols, low success rates, and high R&D investments that are targeting smaller market opportunities.
— Tufts Center for the Study of Drug Development, http://csdd.tufts.edu/ .
Articles in this issue
over 11 years ago
Three-Pronged Approach to Optimizing Trial Monitoringover 11 years ago
Half of All Drugs Today are Developed Through Collaborationsover 11 years ago
Event Examines Key Clinical Trial Adaptation Trendsover 11 years ago
Policymakers Seek New Ways to Streamline R&D and Approvalover 11 years ago
Rebranding 'Risk-Based Monitoring'over 11 years ago
Engaging Tomorrow's Volunteers Through Museum Learningover 11 years ago
Questions and Hopes on New EU Drug Legislationover 11 years ago
ACT coverover 11 years ago
The Metrics Behind High Performing Study Startupsover 11 years ago
Enhancing Trial Enrollment Through 'Goal Programming'over 11 years ago
Shifting Monitoring Paradigms: Challenges and Opportunitiesover 11 years ago
Applied Clinical Trials Digital Edition - June/July 2014Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement